23 . October , 2018 - Tuesday
Check todays hot topics or new products

Find a Drug: Advanced

Please Sign in or Register

All about: Pred Forte

Big Image
Generic Name: prednisolone acetate
Dosage Form: Ophthalmic suspension

sterile

Pred Forte Description

Pred Forte® (prednisolone acetate ophthalmic suspension, USP) 1% is a topical anti-inflammatory agent for ophthalmic use.

Structural Formula:

Chemical Name:

11β,17, 21-Trihydroxypregna-1,4-diene-3, 20-dione 21-acetate

Contains: Active: prednisolone acetate (microfine suspension) 1.0% Preservative: benzalkonium chloride. Inactives: boric acid; edetate disodium; hypromellose; polysorbate 80; purified water; sodium bisulfite; sodium chloride; and sodium citrate. The pH during its shelf life ranges from 5.0 - 6.0.

Pred Forte - Clinical Pharmacology

Prednisolone acetate is a glucocorticoid that, on the basis of weight, has 3 to 5 times the anti-inflammatory potency of hydrocortisone. Glucocorticoids inhibit the edema, fibrin deposition, capillary dilation, and phagocytic migration of the acute inflammatory response, as well as capillary proliferation, deposition of collagen, and scar formation.

Indications and Usage for Pred Forte

Pred Forte® is indicated for the treatment of steroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe.

Contraindications

Pred Forte® suspension is contraindicated in most viral diseases of the cornea and conjunctiva including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal diseases of ocular structures. Pred Forte® suspension is also contraindicated in individuals with known or suspected hypersensitivity to any of the ingredients of this preparation and to other corticosteroids.

Warnings

Prolonged use of corticosteroids may result in glaucoma with damage to the optic nerve, defects in visual acuity and fields of vision, and in posterior subcapsular cataract formation. Prolonged use may also suppress the host immune response and thus increase the hazard of secondary ocular infections.

Various ocular diseases and long-term use of topical corticosteroids have been known to cause corneal and scleral thinning. Use of topical corticosteroids in the presence of thin corneal or scleral tissue may lead to perforation.

Acute purulent infections of the eye may be masked or activity enhanced by the presence of corticosteroid medication.

If this product is used for 10 days or longer, intraocular pressure should be routinely monitored even though it may be difficult in children and uncooperative patients. Steroids should be used with caution in the presence of glaucoma. Intraocular pressure should be checked frequently.

The use of steroids after cataract surgery may delay healing and increase the incidence of bleb formation.

Use of ocular steroids may prolong the course and may exacerbate the severity of many viral infections of the eye (including herpes simplex). Employment of a corticosteroid medication in the treatment of patients with a history of herpes simplex requires great caution; frequent slit lamp microscopy is recommended.

Corticosteroids are not effective in mustard gas keratitis and Sjögren's keratoconjunctivitis.

Contains sodium bisulfite, a sulfite that may cause allergic-type reactions, including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.

Precautions

General:

The initial prescription and renewal of the medication order beyond 20 milliliters of Pred Forte® suspension should be made by a physician only after examination of the patient with the aid of magnification, such as slit lamp biomicroscopy, and, where appropriate, fluorescein staining. If signs and symptoms fail to improve after 2 days, the patient should be re-evaluated.

As fungal infections of the cornea are particularly prone to develop coincidentally with long-term local corticosteroid applications, fungal invasion should be suspected in any persistent corneal ulceration where a corticosteroid has been used or is in use. Fungal cultures should be taken when appropriate.

If this product is used for 10 days or longer, intraocular pressure should be monitored (see WARNINGS).

Information for patients:

If inflammation or pain persists longer than 48 hours or becomes aggravated, the patient should be advised to discontinue use of the medication and consult a physician.

This product is sterile when packaged. To prevent contamination, care should be taken to avoid touching the bottle tip to eyelids or to any other surface. The use of this bottle by more than one person may spread infection. Keep bottle tightly closed when not in use. Keep out of the reach of children.

Carcinogenesis, Mutagenesis, Impairment of Fertility:

No studies have been conducted in animals or in humans to evaluate the potential of these effects.

Pregnancy Category C

Prednisolone has been shown to be teratogenic in mice when given in doses 1-10 times the human dose. There are no adequate well-controlled studies in pregnant women. Prednisolone should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Dexamethasone, hydrocortisone, and prednisolone were ocularly applied to both eyes of pregnant mice five times per day on days 10 through 13 of gestation. A significant increase in the incidence of cleft palate was observed in the fetuses of the treated mice.

Nursing Mothers:

It is not known whether topical ophthalmic administration of corticosteroids could result in sufficient systemic absorption to produce detectable quantities in breast milk. Systemically administered corticosteroids appear in human milk and could suppress growth, interfere with endogenous corticosteroid production, or cause other untoward effects. Because of the potential for serious adverse reactions in nursing infants from prednisolone, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Pediatric Use:

Safety and effectiveness in pediatric patients have not been established.

Geriatric Use:

No overall differences in safety or effectiveness have been observed between elderly and younger patients.

Adverse Reactions

Adverse reactions include, in decreasing order of frequency, elevation of intraocular pressure (IOP) with possible development of glaucoma and infrequent optic nerve damage, posterior subcapsular cataract formation, and delayed wound healing.

Although systemic effects are extremely uncommon, there have been rare occurrences of systemic hypercorticoidism after use of topical steroids.

Corticosteroid-containing preparations have also been reported to cause acute anterior uveitis and perforation of the globe. Keratitis, conjunctivitis, corneal ulcers, mydriasis, conjunctival hyperemia, loss of accommodation and ptosis have occasionally been reported following local use of corticosteroids.

The development of secondary ocular infection (bacterial, fungal, and viral) have occurred. Fungal and viral infections of the cornea are particularly prone to develop coincidentally with long-term applications of steroids. The possibility of fungal invasion should be considered in any persistent corneal ulceration where steroid treatment has been used (see WARNINGS).

Transient burning and stinging upon instillation and other minor symptoms of ocular irritation have been reported with the use of Pred Forte® suspension. Other adverse events reported with the use of Pred Forte® suspension include: visual disturbance (blurry vision); foreign body sensation; and allergic reactions.

Overdosage

Overdosage will not ordinarily cause acute problems. If accidentally ingested, drink fluids to dilute.

Pred Forte Dosage and Administration

Shake well before using. Instill one to two drops into the conjunctival sac two to four times daily. During the initial 24 to 48 hours, the dosing frequency may be increased if necessary. Care should be taken not to discontinue therapy prematurely.

If signs and symptoms fail to improve after 2 days, the patient should be re-evaluated (see PRECAUTIONS).

How is Pred Forte Supplied

Pred Forte® (prednisolone acetate ophthalmic suspension, USP ) 1% is supplied sterile in opaque white LDPE plastic bottles with droppers with white high impact polystyrene (HIPS) caps as follows:

1 mL in 5 mL bottle - NDC 11980-180-01

5 mL in 10 mL bottle - NDC 11980-180-05

10 mL in 15 mL bottle - NDC 11980-180-10

15 mL in 15 mL bottle - NDC 11980-180-15

Note: Store at temperatures up to 25°C (77°F). Protect from freezing. Store in an upright position.

Rx Only

March 2004

© 2004 Allergan, Inc.
Irvine, CA 92612, U.S.A.
® Marks owned by Allergan, Inc.

6294X

71592US10M


Pred Forte (prednisolone acetate)
PRODUCT INFO
Product Code 11980-180 Dosage Form SUSPENSION
Route Of Administration OPHTHALMIC DEA Schedule
INGREDIENTS
Name (Active Moiety) Type Strength
prednisolone acetate (prednisolone) Active 10 MILLIGRAM  In 1 MILLILITER
boric acid Inactive  
edetate disodium Inactive  
hypromellose Inactive  
polysorbate 80 Inactive  
water Inactive  
sodium bisulfite Inactive  
sodium chloride Inactive  
sodium citrate Inactive  
benzalkonium chloride Inactive  
IMPRINT INFORMATION
Characteristic Appearance Characteristic Appearance
Color Score
Shape Symbol
Imprint Code Coating
Size
PACKAGING
# NDC Package Description Multilevel Packaging
1 11980-180-01 1 MILLILITER In 1 BOTTLE, PLASTIC None
2 11980-180-05 5 MILLILITER In 1 BOTTLE, PLASTIC None
3 11980-180-10 10 MILLILITER In 1 BOTTLE, PLASTIC None
4 11980-180-15 15 MILLILITER In 1 BOTTLE, PLASTIC None

Revised: 07/2006

Recent Drug Updates at DrugIndexOnline:





Anastrozole Anastrozole
Pronouncation: (an-ASS-troe-zole) Class: Aromatase inhibitor Trade Names: Arimidex - Tablets for oral use 1 mg Mechanism of Action Pharmacology A selective nonsteroidal aromatase inhibitor. It lowers serum estradiol concentrations. Pharmacokinetics Distribution 40% protein bound. Metabolism Metabol more...

Didanosine Delayed-Release Enteric-Coated Capsules Didanosine Delayed-Release Enteric-Coated Capsules
Generic Name: Didanosine Delayed-Release Enteric-Coated Capsules (dye-DAN-oh-seen) Brand Name: Videx EC Didanosine Delayed-Release Enteric-Coated Capsules may cause serious and sometimes fatal inflammation of the pancreas (pancreatitis). This has occurred in patients who have just started taking more...

Fluorometholone Fluorometholone
Generic Name: Fluorometholone Ophthalmic Suspension (flure-oh-METH-oh-lone) Brand Name: Examples include Fluor-Op and FML ForteFluorometholone is used for:Treating inflammation (swelling, warmth, redness, pain) of the eyes and eyelids. Fluorometholone is a corticosteroid. Exactly how Fluorome more...

Fortical Spray Fortical Spray
Generic Name: Calcitonin Salmon Nasal Spray (KAL-si-TOE-nin SA-mon) Brand Name: Examples include Fortical and MiacalcinFortical Spray is used for:Treating osteoporosis (fragile or brittle bones) in certain women who have been past menopause for more than 5 years. It should be used along with ad more...

Isoniazid Tablets Isoniazid Tablets
Dosage Form: Tablets  JUNE 1998 1000660104  Rx only WARNING: Severe and sometimes fatal hepatitis associated with Isoniazid therapy has been reported and may occur or may develop even after many months of treatment. The risk of developing hepatitis is age related. Approximate case rat more...

Isordil Isordil
Generic Name: isosorbide dinitrate (eye soe SOR bide dye NYE trate) Brand Names: Dilatrate-SR, ISDN, Isordil, Isordil Tembids, Isordil Titradose, Sorbitrate What is Isordil (isosorbide dinitrate)? Isosorbide dinitrate is in a group of drugs called nitrates. Isosorbide dinitrate dilates more...

Levocetirizine Dihydrochloride Levocetirizine Dihydrochloride
Pronouncation: (LEE-voe-se-TIR-a-zeen dye-HYE-droe-KLOR-ide) Class: Antihistamine Trade Names: Xyzal - Tablets 5 mg Mechanism of Action Pharmacology Inhibition of H 1 receptors. Pharmacokinetics Absorption Rapidly and extensively absorbed. T max is 0.9 h. C max is 270 ng/mL and 308 ng/mL after sing more...

Nitroglycerin Transdermal Nitroglycerin Transdermal
Generic Name: nitroglycerin Dosage Form: Transdermal system Rx only Prescribing Information Nitroglycerin Transdermal Description Nitroglycerin is 1,2,3-propanetriol, trinitrate, an organic nitrate whose structural formula is: and whose molecular weight is 227.09. The organic nitrates are vaso more...